Alternatives to Temozolomide If You Can't Fill Your Prescription

Temozolomide (Temodar) is the standard-of-care chemotherapy for glioblastoma (GBM) and certain other brain tumors, but what happens when your prescription can't be filled in time — or at all? While every treatment decision must be made by your oncologist based on your specific diagnosis and medical history, understanding your options can help you have a more informed conversation with your care team.

Important: Never stop or switch a chemotherapy regimen without guidance from your oncologist. This article is for informational purposes only. Your doctor must approve any changes to your treatment plan.

Why Temozolomide Is Hard to Replace

Temozolomide has a unique set of properties that make it the preferred chemotherapy for GBM. It crosses the blood-brain barrier effectively after oral administration, it is relatively well tolerated, and decades of clinical data support its use. The Stupp protocol — temozolomide plus radiation followed by temozolomide maintenance — is backed by Phase 3 randomized trial evidence showing improved survival. No alternative replicates all of these advantages. That said, several agents are used in specific clinical situations.

Alternative 1: Lomustine (CCNU, Gleostine)

Lomustine is another oral alkylating agent (a nitrosourea) used in brain tumor treatment. It is FDA-approved for brain tumors and Hodgkin's lymphoma. Lomustine is commonly used in recurrent GBM, often in combination with temozolomide in the CCNU+TMZ regimen. It can cause delayed and prolonged myelosuppression (particularly thrombocytopenia), and dosing intervals are typically every 6 weeks. If temozolomide is temporarily unavailable, some oncologists may consider lomustine as part of a revised regimen — particularly in the recurrent/maintenance setting.

Alternative 2: Carmustine (BCNU/BiCNU or Gliadel Wafers)

Carmustine is a nitrosourea alkylating agent available in two forms. As intravenous BiCNU, it can be used for GBM, often in combination with other agents. As Gliadel wafers, it is surgically implanted directly into the brain tumor cavity at the time of resection, providing localized chemotherapy. Gliadel wafers are FDA-approved for initial treatment of high-grade malignant glioma as an adjunct to surgery and radiation. Carmustine does not replace the ongoing oral maintenance role of temozolomide but may be relevant in the surgical setting.

Alternative 3: Bevacizumab (Avastin)

Bevacizumab (Avastin) is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), blocking tumor blood vessel formation. It is FDA-approved for recurrent GBM. Bevacizumab is given intravenously every 2 weeks and is often used when temozolomide has failed or is not tolerated. It is not typically used as a first-line substitute for temozolomide during initial treatment, but it is a major option in the recurrent setting. Biosimilars to bevacizumab (such as Mvasi, Zirabev, and Alymsys) are also available.

Alternative 4: Procarbazine (in PCV Regimen)

Procarbazine is an oral alkylating agent used as part of the PCV regimen (procarbazine, lomustine/CCNU, and vincristine). PCV is a standard regimen for IDH-mutant grade 2-3 gliomas and is sometimes used in anaplastic astrocytoma. In patients with low-grade gliomas who cannot access temozolomide, PCV may be an alternative that your neuro-oncologist discusses.

Alternative 5: Tumor Treating Fields (Optune)

Tumor Treating Fields (TTF) therapy via the Optune device uses alternating electric fields to disrupt tumor cell division. It is FDA-approved for GBM and is typically used alongside temozolomide maintenance, not as a replacement. However, if a patient cannot tolerate chemotherapy, TTF may be discussed as a non-pharmacological component of a revised plan.

What to Do If You Cannot Get Temozolomide in Time

If you are facing a delay filling your temozolomide prescription, here are immediate steps to take:

1. Call your oncologist's office immediately. They need to know about the delay to advise on next steps.
2. Use medfinder to check nearby pharmacies. medfinder.com can check multiple pharmacies near you simultaneously to find where your medication is in stock.
3. Ask about specialty pharmacy transfer. Your oncology team can redirect your prescription to a specialty pharmacy that has stock on hand.
4. Ask about hospital pharmacy access. Your cancer center's pharmacy may be able to dispense a short bridge supply while the rest is located.

Bottom Line

Temozolomide is difficult to replace in newly diagnosed GBM, but alternatives exist in the recurrent and refractory settings. The most important thing is to communicate immediately with your oncology team if you face a fill delay. In the meantime, use every available tool to find your prescription — including our guide on finding temozolomide in stock.